High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy

• Karin Tyralla,

  Affiliation Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany

  ⨯
• Marcin Adamczak,

  Affiliations Department of Pathology, University of Heidelberg, Heidelberg, Germany, Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian University School of Medicine, Katowice, Poland

  ⨯
• Kerstin Benz,

  Affiliation Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany

  ⨯
• Valentina Campean,

  Affiliation Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany

  ⨯
• Marie-Luise Gross,

  Affiliation Department of Pathology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Karl F. Hilgers,

  Affiliation Department of Internal Medicine-Nephrology, University of Erlangen-Nürnberg, Erlangen, Germany

  ⨯
• Eberhard Ritz,

  Affiliation Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany

  ⨯
• Kerstin Amann

  * E-mail: kerstin.amann@uk-erlangen.de

  Affiliation Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany

  ⨯